Author:
Du Lei,Qian Xuan,Li Yuan,Li Xi-zhi,He Lin-lin,Xu Liu,Liu Yi-qi,Li Cheng-cheng,Ma Pu,Shu Fang-lin,Lu Qian,Yin Xiao-xing
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference42 articles.
1. Rossing P. Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history. Curr Diabetes Rep. 2006;6:479–83.
2. Kanwar YS, Sun L, Xie P, Liu FY, Chen S. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol. 2011;6:395–423.
3. Ziyadeh FN. The extracellular matrix in diabetic nephropathy. Am J Kidney Dis Off J Natl Kidney Found. 1993;22:736–44.
4. Xuan YW, Liao M, Zhai WL, Peng LJ, Tang Y. MicroRNA-381 inhibits lung adenocarcinoma cell biological progression by directly targeting LMO3 through regulation of the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition. Eur Rev Med Pharmacol Sci. 2019;23:8411–21.
5. Gurzu S, Turdean S, Kovecsi A, Contac AO, Jung I. Epithelial–mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: an update. World J Clin Cases. 2015;3:393–404.
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献